I realize I am being Captain Obvious with this post but

New Post Public Reply Private Reply Replies (1) Message Board
Mo
474
I realize I am being Captain Obvious with this post but whoever the big money entity is that is funding SS is really overpaying for someone who is not very good at their trade. Below you can see that SS is too lazy to change his own alias’s posted FUD and regurgitates it word for word. SS has tried to disrupt this board with multiple aliases but most longs have been blocking their posts and no one is being fooled. Btw, Squatty please spare us the drama about how much you despise your other self.
=======================================
scottsmith
Tuesday, 12/11/18 08:03:52 PM
Re: None
Post # of 251010

Emailed to me by a colleague :

“So what is the consensus on BTD?

Has it been long enough that an answer would have been given?

If it was granted would they have announced it or is it being held under a CDA related to the terms sheet?

If it wasn't granted, why not?

If not, is it because the sample size on the high-dose chemo was too small?

Is anyone worried that we might be told to do a 2B with a larger sample size of high-dose cisplatin?

Is there anyone with the experience to answer these questions?”
===========================
Posted On: 12/11/2018 6:17:39 PM

Posted By: Squar

So what is the consensus on BTD?

Has it been long enough that an answer would have been given?

If it was granted would they have announced it or is it being held under a CDA related to the terms sheet?

If it wasn't granted, why not?

If not, is it because the sample size on the high-dose chemo was too small?

Is anyone worried that we might be told to do a 2B with a larger sample size of high-dose cisplatin?

Is there anyone with the experience to answer these questions?

Go IPIX
=======================================
Posted On: 11/17/2018 10:21:24 PM
Posted By: Squar
Re: TheDane #51237
The 40 million plus shares pushed onto the market from Aspire.
The relentless smear campaign.
No money for B-ABSSSI phase 3.
Prurisol phase 2 (it was not a phase 2a at the time) results not good enough for phase 3.
Prurisol 2b interim canceled, results delayed indefinitely by lack of payment to CRO.

These all provided ample suppressive fire for the shorts to continue working the stock.

Also, and I know it's hard for some here to believe, there are actually people out there who do not believe IPIX will make a deal. If you're one of those people, shorting here makes total sense.

It's short/cover, short/cover, short/cover. Your numbers come out much bigger than with a single trade where 100% is the max you can earn.

Short at $4.00
Cover at $1.00 to make at 75% return.
Short at $1.00 with all those profits and releverage
Cover at $0.25 to make another 75% return.
Short at $0.25 with all those profits and releverage
Cover at $0.125 to make another 50% return.

That's a 350% ($1000 in, $4500 out) return to here.

Not much meat left on the bone right? Wrong.

Short at $0.125 with all those profits and releverage
Cover at $0.0625 to make another 50% return

That's at 580% return over all.

Shorting is great money if IPIX doesn't catch you off guard with a buyout. That won't happen if you short against your long position as a hedge. Short, turn a profit, split the profit between more shorting and averaging down the long position. Ring that goose's neck til she drops the gold eggs.


Read More: https://investorshangout.com/post/view?id=526...z5XiA2et1j

________________________________________

Posted On: 03/24/2018 5:01:06 PM

Posted By: Phteven C

Re: Drano #43643

I think most of these shorts sellers are actually net longs working the trades. Take this sample IPIX portfolio:

100K core long position
30K long trade position
30K short position

I suspect they are long term bulls so they are comfortable being long 100K-130K at any time but they will take a 30K short position when they think a temporary peak has been hit and then cover when it dips down. This means they can make money trading the volatility, lowering their cost basis, and still be guarenteed a 100K long position in the even of a big announcement. The short position is not ever at risk because the 30K long trading position cancels it out.

On a stock like IPIX, which has declined steadily the past three years, it would have been a very wise strategy to use. Since the short interest is miniscule (less than 1% of the OS), the borrowing costs would be quiet small as well.

This of course neglects any sort of naked short position hiding under the water but the premise holds the same regardless. Only an idiot shorts something like this without a hedge.

Wish I was smart enough to do this.

Go IPIX!
==============================
See any writing style similarities on the above????????


Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FiEE Rockets to Profitability with 382% Revenue Surge

Updated Category News Views 170

Big Moves in the Tech Jungle: FiEE's Comeback Let's chew the fat on FiEE, Inc., a company that's left its hardware-heavy past in the dust and grabbed the bull by the horns with fresh, AI-driven brand tech solutions. We're talking a whopping 382.1% revenue increase. Now, that's not chump change. From barely scraping $2 million last year to raking in $9.6 million just for...

Continue Reading
Interactive Donor Recognition: Beyond GivingTuesday

Updated Category News Views 98

Crafting Stories That Endure You ever notice how some things just fade away after the holidays? Schools don't want their donor stories to go out like last year's tinsel. Rocket Alumni Solutions strikes right at the core of this concern. They recommend crafting donor recognition that lasts beyond GivingTuesday, by anchoring the story in the school's community. This isn't...

Continue Reading
Health Net Invests $3 Million in Stockton Housing

Updated Category News Views 145

Putting a Roof Over Stockton's Head The talk of the town in Stockton is Health Net stepping up with a $3 million investment. This isn't just dropping loose change in a jar; it's about tackling a mammoth issue—making affordable housing more than just a pipe dream for 75 families. Community-driven, they say. What a cozy way to paint a picture of bridging that brutal gap...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 24

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Nonprofit and Partners Gift Homes to Veterans

Updated Category News Views 87

A Heartfelt Gesture on Veterans Day Now this is the kind of story that gets you right in the gut. On November 9, two veterans, who were likely walking into a golf club thinking it was just another evening, were handed the keys to a future they might have only dreamt of: a mortgage-free home. Operation Finally Home, backed by the big names like Lennar and the patriotic...

Continue Reading
Biointron's RushDATA™: Speeding Up Antibody Discovery

Updated Category News Views 227

A New Chapter in Antibody Discovery Well, color me intrigued. Biointron, a name you'd recognize if you've got even a toe in the biotech pond, just threw a serious curveball into the antibody discovery game with RushDATA™—an AI- and machine learning-driven platform that's packing a punch. And it's not just about throwing tech buzzwords around; this thing clocks...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 32

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
Cardinal Infrastructure Faces Legal Scrutiny Amid Losses

Updated Category News Views 100

Cardinal Infrastructure Group Under Intense Investor Scrutiny Well, ain't this a messy soup of financial blunders? Cardinal Infrastructure Group (Nasdaq: CDNL) finds itself on the sharp end of a potential securities law investigation, thanks to some colossal screw-ups in managing project costs and estimates. Investors are rightly pissed after the company's shares...

Continue Reading
KeyCorp Plans Redemption of Series E Preferred Stock

Updated Category News Views 112

KeyCorp Drops a Major Redemption Bombshell Out of the blue, KeyCorp (NYSE: KEY) just tossed a curveball at investors with the announcement they’re redeeming every last one of their Series E Fixed-to-Floating Rate Perpetual Non-Cumulative Preferred Stock shares come December 15, 2026. This move is bound to stir the pot a bit even if you’ve been around the block a few...

Continue Reading
PenFed Fuels Aggie Spirit with Blackout Game Activation

Updated Category News Views 156

A Different Kind of Game Day Experience Ah, there's nothing quite like the vibrancy of a Texas A&M game day, especially when it's a blackout event. On November 14, fans aren't just getting the good old college football thrills; they're diving headfirst into an extravaganza, courtesy of PenFed Credit Union. You might know them as the go-to credit union for military folks,...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding the Shift in Investor Sentiment for JLL Stock

Updated Category News Views 139

Analyzing Investor Sentiment for Jones Lang LaSalle Jones Lang LaSalle's (JLL) stock has seen some interesting trends recently. Notably, the short percent of float has decreased by 31.32% since the last reporting period, indicating a significant shift in how traders are positioning themselves with respect to the stock. Currently, there are approximately 775 thousand...

Continue Reading
Innovative DN Series 300 and 350 Cash Dispensers from Diebold

Updated Category News Views 250

Revolutionizing Self-Service Banking with DN Series 300 and 350 Diebold Nixdorf, a forward-thinking leader in the world of banking technology, has introduced its latest innovations, the DN Series 300 and 350 cash dispensers. These state-of-the-art machines are transforming self-service banking experiences worldwide. The key to their advancement lies in the newly...

Continue Reading
Patient Safety at Risk: New Bill Threatens Consumer Protections

Updated Category News Views 303

Patient Safety at Risk: New Bill Threatens Consumer Protections Recent developments in California’s legislative assembly have raised serious concerns about patient safety following the proposal of a new bill aimed at reshaping how the Medical Board handles physicians with substance abuse issues. This bill, AB 408, is set to be discussed in the Assembly’s Business &...

Continue Reading
Exploring China's Sustainable Development at the 'Green Dream' Exhibition

Updated Category News Views 132

China's Green Dream Exhibition in Berlin Recently, an engaging photo exhibition titled "Green Dream: Themed Exhibition on the New Journey of Chinese Modernization" attracted international audiences in Berlin. This remarkable event highlighted China's ongoing efforts and achievements in sustainable development and modernization. Importance of Green Development Green...

Continue Reading
Innovative PLATE PROTECTOR Revolutionizes Weight Plate Usage

Updated Category News Views 267

Introducing the PLATE PROTECTOR for Enhanced Safety The world of fitness is evolving rapidly, and protecting our equipment is becoming increasingly crucial. The creator of the ingenious PLATE PROTECTOR aims to change how weight plates are treated in gyms and fitness centers. The innovative design presents an easy-to-use solution for safeguarding equipment and...

Continue Reading